Publications by authors named "Therese Staub"

Claim this Profile
E
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial.
Clément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, Simon Jamard, François Goehringer, Thérèse Staub

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary analysis of hand disinfection use by travellers and their colonisation-risk with multi-resistant bacteria: A proof-of-concept study.
Tobias Kaspers, Cosima Berdin, Thérèse Staub, Barbara Gärtner, Fabian Berger

Travel Med Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic and Genetic predictors and risk scores of cardiovascular diseases in persons living with HIV.
Tanvi Mehta, Lillian Haine, Jason Baker, Cavan Reilly, Daniel Duprez, Therese Staub

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmasking the Psychological Landscape of Long COVID: A Cluster-analytical Approach.
Raquel Gómez Bravo, Alexandre Infanti, Joël Billieux, Mark Ritzen, Sandra Nischwitz, Thérèse Staub

Biopsychosoc Sci Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, Lucie de Gastines, Drifa Belhadi, Thérèse Staub

Clin Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
Maya Hites, Clément R Massonnaud, Eva Larranaga Lapique, Drifa Belhadi, Simon Jamard, Thérèse Staub

J Infect· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
Nadège Néant, Guillaume Lingas, Alexandre Gaymard, Drifa Belhadi, Maya Hites, Thérèse Staub

CPT Pharmacometrics Syst Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Vic Arendt, Therese Staub

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort.
Sandra E Safo, Lillian Haine, Jason Baker, Cavan Reilly, Daniel Duprez, Therese Staub

J Am Heart Assoc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Noémie Mercier, Drifa Belhadi, Aline DeChanet, Christelle Delmas, Juliette Saillard, Thérèse Staub

Pharmacol Res Perspect· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Jens D Lundgren, Abdel G Babiker, Shweta Sharma, Birgit Grund, Andrew N Phillips, Therese Staub

NEJM Evid· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone.
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Victor Arendt, Georges Gilson, Therese Staub

Curr Issues Mol Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
Wendy P Bannister, T Christopher Mast, Stéphane de Wit, Jan Gerstoft, Lothar Wiese, Thérèse Staub

AIDS· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational cohort study of rilpivirine (RPV) utilization in Europe.
Alessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, Bastian Neesgaard, Stephane De Wit, Therese Staub

AIDS Res Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity.
Aurélie Fischer, Lu Zhang, Abir Elbéji, Paul Wilmes, Pauline Oustric, Therese Staub

Open Forum Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
Eveline Santos da Silva, Michel Kohnen, Georges Gilson, Therese Staub, Victor Arendt

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, Drifa Belhadi, Gilles Peytavin, Thérèse Staub

J Antimicrob Chemother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Thérèse Staub

Lancet Infect Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.

Clin Microbiol Infect· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, Maude Bouscambert-Duchamp, Drifa Belhadi, Thérèse Staub

Clin Microbiol Infect· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
Lauren Greenberg, Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Therese Staub

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021.
Thérèse Staub, Vic Arendt, Esther Calvo Lasso de la Vega, Pierre Braquet, Christian Michaux

Euro Surveill· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study.
Guy Fagherazzi, Aurélie Fischer, Fay Betsou, Michel Vaillant, Isabelle Ernens, Therese Staub

BMJ Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
Amanda Mocroft, Lene Ryom, Cristiana Oprea, Qiuju Li, Andri Rauch, Therese Staub

AIDS· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe.
Bastian Neesgaard, Annegret Pelchen-Matthews, Lene Ryom, Eric Florence, Lars Peters, Therese Staub

AIDS· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis